Adrenergic Blockers has 47 known drug interactions based on U.S. FDA drug labeling data. 16 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Anakinra, Clindamycin Phosphate, Dobutamine. Patients taking Adrenergic Blockers should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 47
- Major
- 16
- Moderate
- 31
Major (16)
- Adrenergic Blockers + Anakinra— Use of KINERET in combination with TNF blocking agents is not recommended due to increased serious infections.
- Adrenergic Blockers + Clindamycin Phosphate— Clindamycin has neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Sh…
- Adrenergic Blockers + Dobutamine— Dobutamine may be ineffective if recently preceded by β-blockers; peripheral vascular resistance may increase.
- Adrenergic Blockers + Galantamine— Synergistic effect expected when similar neuromuscular blocking agents are given concurrently with galantamine.
- Adrenergic Blockers + Galantamine Hydrobromide— Synergistic effect expected when similar neuromuscular blocking agents given concurrently with galantamine.
- Adrenergic Blockers + Magnesium Sulfate Heptahydrate— Excessive neuromuscular block has occurred; these drugs should be administered concomitantly with caution.
- Adrenergic Blockers + Magnesium Sulfate In Dextrose— Excessive neuromuscular blockade may occur; concomitant use requires caution.
- Adrenergic Blockers + Mannitol— Electrolyte imbalances caused by mannitol may result in cardiac adverse reactions. Monitor serum electrolytes and discon…
- Adrenergic Blockers + Minocycline Hydrochloride— Potentially serious drug interactions may occur when intravenous magnesium sulfate is given concomitantly with neuromusc…
- Adrenergic Blockers + Oxycodone Hydrochloride— May enhance neuromuscular blocking action and produce increased respiratory depression.
- Adrenergic Blockers + Phenylephrine Hci— Increase the pressor effect of phenylephrine hydrochloride.
- Adrenergic Blockers + Phenylephrine Hydrochloride— Increase the pressor effect of phenylephrine hydrochloride.
- Adrenergic Blockers + Phenylephrine Hydrochloride Injection, Solution— Beta-adrenergic blockers increase pressor effect of phenylephrine hydrochloride.
- Adrenergic Blockers + Rilonacept— Concomitant administration associated with increased risk of serious infections and neutropenia. Not recommended.
- Adrenergic Blockers + Tobramycin Sulfate— Concurrent use may cause prolonged respiratory paralysis. Can be reversed by calcium salts but mechanical assistance may…
- Adrenergic Blockers + Verapamil Hydrochloride— Concomitant use may result in exaggerated hypotensive response. In rare instances with severe cardiomyopathy or recent M…
Moderate (31)
- Adrenergic Blockers + Amphetamine Sulfate— Amphetamines inhibit the effects of adrenergic blockers.
- Adrenergic Blockers + Chlorthalidone— Chlorthalidone potentiates the action of ganglionic peripheral adrenergic blocking drugs, increasing antihypertensive ef…
- Adrenergic Blockers + Clindamycin Hydrochloride— Clindamycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents; use with…
- Adrenergic Blockers + Clindamycin In 5 Percent Dextrose— Clindamycin has neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; us…
- Adrenergic Blockers + Clindamycin Palmitate Hydrochloride— Clindamycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents; use with…
- Adrenergic Blockers + Clindamycin Phosphate 1%— Clindamycin may enhance the action of neuromuscular blocking agents due to its neuromuscular blocking properties. Use wi…
- Adrenergic Blockers + Clindamycin Phosphate And Benzoyl Peroxide— Clindamycin has neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Us…
- Adrenergic Blockers + Clindamycin Phosphate And Tretinoin— Clindamycin has neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Us…
- Adrenergic Blockers + Clindamycin Phosphate And Tretinoin Gel 1.2%/0.025%— Clindamycin component may enhance the action of neuromuscular blocking agents. Use with caution in patients receiving su…
- Adrenergic Blockers + Clindamycin Phosphate Topical Solution Usp, 1%— Clindamycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents. Use with…
- Adrenergic Blockers + Clindamycin Phosphate Topical Usp, 1%— Clindamycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents. Use with…
- Adrenergic Blockers + Clindamycin Phosphate/Benzoyl Peroxide/Adapalene— Clindamycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents. Use with…
- Adrenergic Blockers + Clindamycin, Benzoyl Peroxide— Clindamycin has neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Sh…
- Adrenergic Blockers + Cocaine Hydrochloride Nasal— Concomitant administration may increase risk of cardiovascular adverse reactions.
- Adrenergic Blockers + Dextroamphetamine Saccharate And Amphetamine Aspartate And Dextroamphetamine Sulfate And Amphetamine Sulfate— Adrenergic blockers are inhibited by amphetamines.
- Adrenergic Blockers + Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate— Adrenergic blockers are inhibited by amphetamines, potentially reducing their therapeutic effect.
- Adrenergic Blockers + Dextroamphetamine Sulfate— Amphetamines inhibit the effects of adrenergic blockers.
- Adrenergic Blockers + Doxapram Hydrochloride— Doxapram may temporarily mask the residual effects of neuromuscular blocking agents in patients who have received these …
- Adrenergic Blockers + Furosemide— Potentiation of adrenergic blocking effects occurs with concurrent use.
- Adrenergic Blockers + Furosemide Injection 80 Mg/ 10 Ml— Potentiation occurs with furosemide. Monitor for changes in blood pressure and adjust dose of adrenergic blocking drugs …
- Adrenergic Blockers + Furosemide, Benzalkonium Chloride— Potentiation occurs with ganglionic or peripheral adrenergic blocking drugs.
- Adrenergic Blockers + Lincomycin— Lincomycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents; use with …
- Adrenergic Blockers + Lincomycin Hydrochloride— Lincomycin has neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents; use with …
- Adrenergic Blockers + Lithium Carbonate— Lithium may prolong the effects of neuromuscular blocking agents, requiring cautious use and close monitoring.
- Adrenergic Blockers + Methimazole— Hyperthyroidism increases clearance of beta blockers; dose reduction may be needed when hyperthyroid patient becomes eut…
- Adrenergic Blockers + Niacin— Niacin may potentiate the effects of ganglionic blocking agents, resulting in postural hypotension.
- Adrenergic Blockers + Phendimetrazine Tartrate— Phendimetrazine tartrate may decrease the hypotensive effect of adrenergic neuron blocking drugs.
- Adrenergic Blockers + Phentermine Hydrochloride— Phentermine may decrease the hypotensive effect of these agents.
- Adrenergic Blockers + Sodium Nitroprusside— Hypotensive effect of sodium nitroprusside is augmented by ganglionic blocking agents.
- Adrenergic Blockers + Vasopressin— May increase the effect of vasopressin on mean arterial blood pressure. Hemodynamic monitoring recommended.
- Adrenergic Blockers + Vasopressin In 0.9% Sodium Chloride— May increase vasopressin effect on mean arterial blood pressure. Hemodynamic monitoring recommended; adjust vasopressin …